Management

Market will be driven by the increasing prevalence of gastric cancer, higher levels of health insurance coverage, and improving…

It will be driven by factors including increasing prevalence of infectious diseases, the emergence of more accurate molecular…

With the Indian government coming up with a slew of measures to counter the Chinese invasion in bulk drug manufacturing, can drug…

Advantages such as low cost and less toxicity, which give them an edge over their synthetic counterparts, are spurring the use of…

SynCore Consulting helped a fast growing pharma retail chain, bogged down by snags in its distribution model, improve stock…

It will grow at a CAGR of 7.5 per cent

It will represent a CAGR of 2.89 per cent

The market will see a rise from $1.7 billion in 2015 to $2.7 billion by 2022, says GBI Research

The market will however see a rapid decline to $4.9 billion by 2025, says GlobalData

Pharma companies across the world are racing against time to meet the November 2017 deadline of the US DSCSA followed by the…